# Mohs and Immunofluorescence for Malignant Melanoma In Situ

> **NCT02306512** · NA · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Lentigo Maligna
- Melanoma In Situ

## Interventions

- **PROCEDURE:** H&E
- **PROCEDURE:** IHC MART-1
- **PROCEDURE:** IF MART-1
- **PROCEDURE:** IF cocktail

## Key facts

- **NCT ID:** NCT02306512
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI is leaving the University of Miami
- **Last updated:** 2019-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306512, "Mohs and Immunofluorescence for Malignant Melanoma In Situ". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02306512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*